MoneyWorks4Me

Hind Bio Science - Quaterly Results

31 Jan 2024 Evaluate
A minor change in the total revenue was seen in the December 2023 quarter. The total revenue for the quarter stood at Rs. 3.22 millions against Rs. 3.18 millions during year ago period.The company has announced a 48.94% increase in its profits to Rs . 0.70  millions for the  quarter ended December 2023 compared to Rs. 0.47 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 0.72 millions from 0.49 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 3.22 3.18 1.26 6.39 5.89 8.49 9.22 4.31 113.92
Other Income 0.15 0.00 0.00 0.25 0.00 0.00 0.00 0.00 0.00
PBIDT 0.72 0.49 46.94 0.20 -0.48 -141.67 -0.28 -5.06 -94.47
Interest 0.01 0.01 0.00 0.03 0.02 50.00 0.04 0.05 -20.00
PBDT 0.71 0.48 47.92 0.17 -0.50 -134.00 -0.32 -5.11 -93.74
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.06 0.03 100.00
PBT 0.70 0.47 48.94 0.14 -0.53 -126.42 -0.38 -5.14 -92.61
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -33.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -33.33
PAT 0.70 0.47 48.94 0.14 -0.53 -126.42 -0.40 -5.17 -92.26
Equity 20.50 102.51 -80.00 20.50 102.51 -80.00 20.50 102.51 -80.00
PBIDTM(%) 22.36 15.41 45.11 3.13 -8.15 -138.41 -3.04 -117.40 -97.41
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..